Loading clinical trials...
Loading clinical trials...
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
15 mg dextromethorphan hydrobromide will be better than placebo with respect to reducing the number of coughs over 6 hours and reducing the subjective severity of cough over 6 hours.
In light of protocol changes required due to methodological and operational issues, including background noise in cough recordings which could impact data interpretation, the study has been terminated.
Age
6 - 11 years
Sex
ALL
Healthy Volunteers
No
DMI Research
Pinellas Park, Florida, United States
Concentrics Center for Research
Indianapolis, Indiana, United States
Cyn3rgy Research
Gresham, Oregon, United States
Clinical Research Associates Incorporated
Nashville, Tennessee, United States
Start Date
December 1, 2010
Primary Completion Date
March 1, 2011
Completion Date
March 1, 2011
Last Updated
September 20, 2012
140
ACTUAL participants
Dextromethorphan
DRUG
Placebo
DRUG
Lead Sponsor
Pfizer
Collaborators
NCT06531707
NCT06716645
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05944705